How have INVVY shares performed in 2024?

Indivior's stock was trading at $21.8455 on January 1st, 2024. Since then, INVVY shares have increased by 0.0% and is now trading at $21.8455. View the best growth stocks for 2024 here .

How do I buy shares of Indivior?

Shares of INVVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:INVVY

Indivior (INVVY) Stock Price, News & Analysis

→ This company has increased its dividend every year for 54 years (From DTI) (Ad)

Free INVVY Stock Alerts

$21.85

-0.40 (-1.82%)

(As of 06/9/2023)

Compare

Today's Range: $21.64
▼
$21.85
50-Day Range: $21.85
▼
$21.85
52-Week Range: $14.76
▼
$35.50

Volume: 8,100 shs
Average Volume: 3,825 shs
Market Capitalization: $3.01 billion

P/E Ratio: 20.81
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Headlines

Get Indivior alerts:

Ad DTI

This company has increased its dividend every year for 54 years

There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.

Click here to get them (for Free).

About Indivior Stock (OTCMKTS:INVVY)

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom.

INVVY Stock Price History

30 days | 90 days | 365 days | Advanced Chart

INVVY Stock News Headlines

March 6, 2024 | finance.yahoo.com

Zacks.com featured highlights Modine Manufacturing, Indivior and Interface

February 22, 2024 | marketwatch.com

Indivior Shares Jump on Possible U.S. Listing, Swing to Pretax Profit

April 18, 2024 | Tips4Traders (Ad)

Uncover this 2024 Hidden Gem

Exclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.

February 22, 2024 | msn.com

Indivior shares soar as pharma firm ponders primary listing in the US

February 22, 2024 | msn.com

Drug maker Indivior considers ditching primary UK listing for US

February 22, 2024 | uk.finance.yahoo.com

UPDATE 1-UK-listed Indivior plans shifting to US bourses by summer

February 22, 2024 | ca.news.yahoo.com

Drugmaker Indivior consults on moving primary listing from London to US

February 22, 2024 | finance.yahoo.com

Indivior plans shifting primary listing to U.S.

April 18, 2024 | Tips4Traders (Ad)

Uncover this 2024 Hidden Gem

February 22, 2024 | ft.com

Indivior aims to move primary listing from London to New York

February 22, 2024 | msn.com

Indivior plans primary US listing in another hit to London’s flagging equity market

January 16, 2024 | thetimes.co.uk

Indivior boss brings promise of a pick-me-up for staff

December 20, 2023 | marketwatch.com

Indivior Resolves Patent Disputes With Actavis

December 5, 2023 | lse.co.uk

Indivior and Reckitt land legal boost in UK Suboxone claim

December 5, 2023 | marketwatch.com

Indivior Says UK High Court Strikes Claims Against It and Reckitt Benckiser

November 17, 2023 | lse.co.uk

Indivior to keep Scopia's Jerome Lande on board as agreement extended

November 17, 2023 | marketwatch.com

Indivior Extends Relationship, Board Representation of Major Shareholder

November 17, 2023 | lse.co.uk

UPDATE: Indivior plans up to USD100 million share buyback programme

November 17, 2023 | marketwatch.com

Indivior to Begin $100 Mln Share Buyback

November 9, 2023 | uk.finance.yahoo.com

Indivior Announces Q3 2023 Financial Results

November 9, 2023 | lse.co.uk

Indivior swings to quarterly loss on costs despite strong sales

November 9, 2023 | marketwatch.com

Indivior Swings to Pretax Loss on Higher Costs; Backs Revenue View

October 24, 2023 | reuters.com

Indivior to pay $385 mln to settle Suboxone claims by direct purchasers

October 23, 2023 | thetimes.co.uk

Indivior freed up to fight global crisis

October 23, 2023 | reuters.com

UPDATE 1-Indivior to pay $385 mln to end Suboxone monopoly lawsuits

October 23, 2023 | msn.com

Indivior to pay $385 million to end final Suboxone monopoly lawsuits

October 23, 2023 | msn.com

Indivior settles anti-trust lawsuits worth £316m

See More Headlines

Receive INVVY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Indivior and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/17/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:INVVY
Previous Symbol: NASDAQ:INVVY
CUSIP: N/A
CIK: 1625297
Web: www.indivior.com
Phone: 804-379-1090
Fax: 804-379-1215
Employees: 800
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 20.81
Forward P/E Ratio: 17.62
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $791 million
Price / Sales: 3.81
Cash Flow: $1.15 per share
Price / Cash Flow: 18.94
Book Value: $1.45 per share
Price / Book: 15.07

Miscellaneous

Outstanding Shares: 137,880,000
Free Float: N/A
Market Cap: $3.01 billion
Optionable: Not Optionable
Beta: 0.35

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mark Crossley
Chief Executive Officer & Executive Director
Ryan Preblick
Chief Financial Officer & Executive Director
Christian Heidbreder
Chief Scientific Officer
Cynthia Cetani
Chief Compliance & Integrity Officer
Nina DeLorenzo
Chief Global Impact Officer

Key Competitors

View All Competitors

INVVY Stock Analysis - Frequently Asked Questions

How have INVVY shares performed in 2024?: Indivior's stock was trading at $21.8455 on January 1st, 2024. Since then, INVVY shares have increased by 0.0% and is now trading at $21.8455.
View the best growth stocks for 2024 here.
How do I buy shares of Indivior?: Shares of INVVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:INVVY) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Indivior (INVVY) Stock Price, News & Analysis

About Indivior Stock (OTCMKTS:INVVY)

INVVY Stock Price History

INVVY Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

INVVY Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info